High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum

Journal of General Virology

Volumn 81, Issue 5, 2000, Pages 1165-1174

  Weinberger, Klaus M ^a   Bauer, Tanja ^a   Böhm, Stephan ^a   Jilg, Wolfgang ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; NEUTRALIZING ANTIBODY; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

AMINO ACID SEQUENCE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; HYDROPHILICITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; VIRUS CARRIER; VIRUS GENE; VIRUS MUTANT;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0034010670     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-5-1165     Document Type: Article

References (40)

1. Ackerman, Z., Wands, J. R., Gazitt, Y., Bréchet, C., Kew, M. C. & Shouval, D. (1994). Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. Journal of Hepatology 20, 398-404.
2. Bahn, A., Gerner, P., Martine, U., Bortolotti, F. & Wirth, S. (1997). Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. Journal of Hepatology 27, 973-978.
3. Bartholomew, M. M., Jansen, R. W., Jeffers, L. J., Reddy, K. R., Johnson, L. C., Bunzendahl, H., Condreay, L. D., Tzakis, A. G., Schiff, E. R. & Brown, N. A. (1997). Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349, 20-22.
4. Carman, W. F. (1997). The clinical significance of surface antigen variants of hepatitis B virus. Journal of Viral Hepatitis 4 (Suppl. 1), 11-20.
5. Carman, W. F., Dourakis, S., Karayiannis, P., Crossey, M., Drobner, R. & Thomas, H. C. (1991). Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-alpha. Journal of Medical Virology 34, 114-118.
6. Coursaget, P., Le Cann, P., Leboulleux, D., Diop, M. T., Bao, O. & Coll, A. M. (1991). Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiology Letters 67, 35-38.
7. Friedt, M., Gerner, P., Lausch, E., Trübel, H., Zabel, B. & Wirth, S. (1999). Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29, 1252-1258.
8. Gerner, P. R., Friedt, M., Oettinger, R., Lausch, E. & Wirth, S. (1998). The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of pre-S2-defective particles in chronically infected children. Virology 245, 163-172.
9. Ghany, M. G., Ayola, B., Villamil, F. G., Gish, R. G., Rojter, S., Vierling, J. M. & Lok, A. S. F. (1998). Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27, 213-222.
10. Gonnet, G. H., Cohen, M. A. & Benner, S. A. (1992). Exhaustive matching of the entire protein sequence database. Science 256, 1443-1445.
11. Grethe, S., Monazahian, M., Böhme, I. & Thomssen, R. (1998). Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. Journal of Virology 72, 7692-7696.
12. Honkoop, P., Niesters, H. G., de Man, R. A., Osterhaus, A. D. & Schalm, S. W. (1997). Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. Journal of Hepatology 26, 1393-1395.
13. Hoofnagle, J. H., Seefe, L. B., Bales, Z. B. & Zimmerman, H. J. (1978). Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. The Veterans Administration Hepatitis Cooperative Study Group. New England Journal of Medicine 298, 1379-1383.
14. Hughes, W., Barr, A., Dow, B. C., Follett, E. A. & Barbara, J. A. (1995). A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfusion Medicine 5, 225-230.
15. Jilg, W., Sieger, E., Zachoval, R. & Schätzl, H. (1995). Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 23, 14-20.
16. Joller-Jemelka, H. I., Wicki, A. N. & Grob, P. J. (1994). Detection of HBs antigen in 'anti-HBc alone' positive sera. Journal of Hepatology 21, 269-272.
17. Kann, M. & Gerlich, W. H. (1998). Hepatitis B. In Microbiology and Microbial Infections, vol. 1 Virology, pp. 745-773. Edited by L. Collier, A. Balows & M. Sussman. London: Topley & Wilson.
18. Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A. & Steitz, T. A. (1992). Crystal structure at 3·5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
19. Kroes, A. C. M., Quint, W. G. V. & Heijtink, R. A. (1991). Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. Journal of Medical Virology 35, 96-100.
20. Kwok, S. & Higuchi, R. (1989). Avoiding false positives with PCR. Nature 339, 237-238.
21. Lee, D. S., Huh, K., Lee, E. H., Lee, D. H., Hong, K. S. & Sung, Y. C. (1997). HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. Journal of Gastroenterology and Hepatology 12, 855-861.
22. Melegari, M., Bruno, S. & Wands, J. R. (1994). Properties of hepatitis B virus pre-S1 deletion mutants. Virology 199, 292-300.
23. Melegari, M., Scaglioni, P. P. & Wands, J. R. (1998). Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 27, 628-633.
24. Neifer, S., Molz, B., Sucker, U., Kreuzpaintner, E., Weinberger, K. & Jilg, W. (1997). Hoher Prozentsatz isoliert anti-HBc-positiver Personen unter Strafgefangenen. Gesundheitswesen 59, 409-412.
25. Norder, H., Hammas, B., Larsen, J., Skaug, K. & Magnius, L. O. (1992). Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Archives of Virology Supplementum 4, 116-118.
26. Norder, H., Hammas, B., Lee, S.-D., Bile, K., Couroucé, A.-M., Mushahwar, I. K. & Magnius, L. O. (1993). Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. Journal of General Virology 74, 1341-1348.
27. Pichoud, C., Seignères, B., Wang, Z., Trépo, C. & Zoulim, F. (1999). Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology 29, 230-237.
28. Protzer-Knolle, U., Naumann, U., Bartenschlager, R., Berg, T., Hopf, U., Meyer zum Büschenfelde, K. H., Neuhaus, P. & Gerken, G. (1998). Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27, 254-263.
29. Sánchez-Quijano, A., Jauregui, J. I., Leal, M., Pineda, J. A., Castilla, A., Abad, M. A., Civeira, M. P., Garcia de Pesquera, F., Prieto, J. & Lissen, E. (1993). Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. Journal of Hepatology 17, 288-293.
30. Schätzl, H. M., Sieger, E., Jilg, W., Nitschko, H. & Zachoval, R. (1997). Variability of the hepatitis B surface protein in HBV-infected liver transplant recipients. Journal of Biomedical Science 4, 146-154.
31. Shih, C. M., Lo, S. J., Miyamura, T., Chen, S. Y. & Lee, Y. H. W. (1993). Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. Journal of Virology 67, 5823-5832.
32. Sumazaki, R., Motz, M., Wolf, H., Heinig, J., Jilg, W. & Deinhardt, F. (1989). Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction. Journal of Medical Virology 27, 304-308.
33. Thijssen, E. J., Kroes, A. C., Bos, E., Persijn, G. G. & Rothbarth, P. H. (1993). The significance of complete serological testing for hepatitis B in heart valve banking. Transplantation 56, 82-84.
34. Tipples, G. A., Ma, M. M., Fischer, K. P., Bain, V. G., Kneteman, N. M. & Tyrrell, D. L. (1996). Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24, 714-717.
35. Turner, D. P., Zuckerman, M., Alexander, G. J., Waite, J. & Wreghitt, T. (1997). Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation 63, 775-777.
36. Waters, J. A., Kennedy, M., Voet, P., Hauser, P., Petre, J., Carman, W. & Thomas, H. C. (1992). Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. Journal of Clinical Investigation 90, 2543-2547.
37. Weinberger, K. M., Kreuzpaintner, E. A., Hottenträger, B., Neifer, S. & Jilg, W. (1997). Mutations in the S-gene of hepatitis B virus (HBV) isolates from chronic carriers with anti-HBc as the only serological marker of HBV infection. In Viral Hepatitis and Liver Disease, pp. 138-143. Edited by M. Rizzetto, R. H. Purcell, J. L. Gerin & G. Verme. Turin: Edizioni Minerva Medica.
38. Weinberger, K. M., Zoulek, G., Bauer, T., Böhm, S. & Jilg, W. (1999). A novel deletion mutant of hepatitis B virus surface antigen. Journal of Medical Virology 58, 105-110.
39. Weinberger, K. M., Wiedenmann, E., Böhm, S. & Jilg, W. (2000). Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). Journal of Virological Methods 85, 75-82.
40. Zoulim, F. & Trépo, C. (1998). Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. Journal of Hepatology 29, 151-168.